Pharmadax Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharmadax Inc with three other
companies in this sector in Taiwan:
Taiwan Liposome Co Limited
sales of 49.64 million Taiwanese Dollars [US$1.66 million]
of which 100%
(54.00 million Taiwanese Dollars [US$1.81 million]
of which 61%
was Drug), and
Tpg Biologics Inc
(61.52 million Taiwanese Dollars [US$2.06 million]
Sales increased substantially in 2017:
During the year ended December of 2017, sales at
Pharmadax Inc were 56.21 million Taiwanese Dollars (US$1.88 million).
increase of 1,380.0%
versus 2016, when the company's sales were 3.80 million Taiwanese Dollars.
This was the third consecutive year of growth at Pharmadax Inc.